May 31, 2017
Novartis warns of U.S. price pressure on Sandoz generics
Novartis warned on Wednesday that price pressure on its generics drugs in the United States has intensified in the second quarter, cutting into its Sandoz division’s sales growth in the world’s largest healthcare market.